Current Pharmaceutical Design

Editorial [Hot Topic:Stabilizing the Vulnerable Plaque: The Search for the Magic Bullet (Executive Editors: G. Pasterkamp and M. Daemen)]
pp. 979-982(4)
Authors: Pasterkamp, Gerard; Daemen, Mat

Activation of the Innate Immune System in Atherosclerotic Disease
pp. 983-994(12)
Authors: Oude Nijhuis, M. M.; van Keulen, J. K.; Pasterkamp, G.; Quax, P. H.; V. de Kleijn, D. P.

Current Diagnostic Modalities for Vulnerable Plaque Detection
pp. 995-1001(7)
Authors: Schaar, Johannes A.; Mastik, Frits; Regar, Evelyn; den Uil, Cornelis A.; Gijsen, Frank J.; Wentzel, Jolanda J.; Serruys, Patrick W.; W. van der Stehen, A. F.

Pleiotropic Effects of Statins: Stabilization of the Vulnerable Atherosclerotic Plaque?
pp. 1003-1012(10)
Authors: Akdim, Fatima; van Leuven, Sander I.; P. Kastelein, John J.; G. Stroes, Erik S.

Animal Models to Study Plaque Vulnerability
pp. 1013-1020(8)
Authors: Schapira, K.; Heeneman, S.; A.P. Daemen, M. J.

Oxidized LDL Antibodies in Treatment and Risk Assessment of Atherosclerosis and Associated Cardiovascular Disease
pp. 1021-1030(10)
Authors: Nilsson, Jan; Nordin Fredrikson, Gunilla; Schiopu, Alexandru; Shah, Prediman K.; Jansson, Bo; Carlsson, Roland

Apolipoprotein A-I/HDL Infusion Therapy for Plaque Stabilization-Regression: A Novel Therapeutic Approach
pp. 1031-1038(8)
Author: Shah, P. K.

Chemokines and Atherosclerotic Plaque Progression: Towards Therapeutic Targeting?
pp. 1039-1052(14)
Authors: Kraaijeveld, A. O.; A. de Jager, S. C.; C. van Berkel, T. J.; L. Biessen, E. A.; Jukema, J. W.

Restoring the Dysfunctional Endothelium
pp. 1053-1068(16)
Authors: Osto, Elena; Coppolino, Giuseppe; Volpe, Massimo; Cosentino, Francesco

Multi-Constituent Cardiovascular Pills (MCCP) - Challenges and Promises of Population-Based Prophylactic Drug Therapy for Prevention of Heart Attack
pp. 1069-1076(8)
Authors: Jamieson, Michael J.; Naghavi, Morteza